New guidelines for postpartum GLP-1 use come as prescribing among new mothers has surged in recent years, according to USC Schaeffer research cited by @WSJ.

The ACA failed to bend the cost curve, USC Schaeffer's Dana Goldman writes in @statnews. The good news: We now have the tools to get healthcare costs under control if we're willing to take a hard look at the value of treatments. statnews.com/2026/10/22/aca-…

Medical billing is complex, and patients rarely have insight into how their bills are calculated. A new USC Schaeffer issue brief examines the hidden infrastructure of medical billing and opportunities to improve the system. schaeffer.usc.edu/research/h…

Nearly 40% of FDA advisory committee meetings over a recent 10-year period included a patient or consumer rep with active ties to an advocacy organization funded by drugmakers, according to new USC Schaeffer research in @Health_Affairs Scholar schaeffer.usc.edu/research/f…

Unless their reviews better account for what patients actually pay and their ability to access treatments, prescription drug affordability boards "may alter reimbursement without resolving the problem they were created to address," writes USC Schaeffer's William Padula.

A CA ballot proposal to tax billionaires is being pitched as a way to offset federal healthcare cuts. However, USC Schaeffer’s Glenn Melnick tells @KFFHealthNews that its ambiguous language could allow lawmakers to use the money for other purposes. marketplace.org/story/2026/1…

New treatments that can slow #Alzheimers progression could provide significant value across society, with even greater benefits when treatment starts earlier, according to new USC Schaeffer research. schaeffer.usc.edu/research/e…

Dementia's economic impact is estimated to hit $818B this year and continue growing. A new interactive tool from USC Schaeffer shows how dementia and new interventions may shape health and economic outcomes over the next 25 years. schaeffer.usc.edu/cost-of-de…

ER visits among foreign-born patients dropped sharply at L.A. hospitals as immigration enforcement intensified last year, new USC Schaeffer research finds. When foreign-born patients did seek care, they were more likely to be hospitalized. schaeffer.usc.edu/research/i…

The collapse of community is a threat to democracy. Young people didn’t create this problem, but they have power to fix it, former UK Prime Minister Gordon Brown of #USCSchaeffer and Robert Putnam told an audience at the @USC Capital Campus last week. schaeffer.usc.edu/research/g…

Postpartum GLP-1 use has increased sharply in the US. Nearly 1 in 6 new mothers with type 2 diabetes were prescribed a GLP-1 last year, while prescriptions have risen fastest for obesity and overweight, finds new USC Schaeffer research in @JAMA_current. schaeffer.usc.edu/research/g…

States have already allocated billions of dollars from major opioid settlements. The largest share, about 40%, is going toward unknown purposes, finds an analysis of publicly reported data led by USC Schaeffer's Rosalie Liccardo Pacula. schaeffer.usc.edu/research/o…

More than 1 in 5 older adults are taking potentially risky combinations of prescription drugs, according to new research from USC Schaeffer's Dima Qato. schaeffer.usc.edu/research/o…

A proposal to tie Medicare physician pay increases to inflation represents a retreat from using sweeping financial incentives to influence how doctors provide care, USC Schaeffer’s Paul Ginsburg told @statnews. statnews.com/2026/09/24/pati…

As policymakers weigh changes to the No Surprises Act’s overburdened arbitration process, USC Schaeffer's Erin Duffy writes that longstanding commercial arbitration and litigation systems offer important lessons for reform. healthaffairs.org/content/fo…

Older Americans appear ready to embrace a vaccine that would help prevent dementia. New USC Schaeffer research finds nearly 3 in 4 older adults would be interested in receiving a vaccine that could cut the risk of dementia in half. schaeffer.usc.edu/research/o…

New blood tests can detect signs of #Alzheimers before symptoms appear, creating a critical opportunity for early intervention. Congress should pass bipartisan legislation allowing Medicare coverage, USC Schaeffer's Joe Grogan writes in @RealClearHealth. realclearhealth.com/articles…

A bill before the House Ways and Means Committee would undermine MedPAC's ability to conduct independent analysis, warned USC Schaeffer Sr. Scholar Paul GInsburg. schaeffer.usc.edu/research/c…

Very few patients with #Alzheimers are referred to or consider joining clinical trials. Reimbursing providers for counseling patients about trial participation could make a difference, USC Schaeffer experts wrote to CMS. schaeffer.usc.edu/research/c…